Answers are grounded in this paper and cite their sources.
Here, we review the experiences of the pneumococcal vaccine community in the adoption of cell lines for bioassays. We have drawn upon successes and failures in the development of in vitro functional assays reported by the international vaccine community, descriptions of the cell line by its
No takes yet. Share an insight, caveat, or question.
Fleck et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: